The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | 1,673 | -5,239 | -13,361 | -5,353 |
| Depreciation and amortization | 2,791 | 2,184 | 2,037 | 8,512 |
| Provision for credit loss reserve | -10 | 0 | 12 | 208 |
| Stock-based compensation | 6,755 | 5,345 | 7,304 | 20,047 |
| Goodwill impairment | - | - | 0 | 0 |
| Non-cash interest expense | 763 | 881 | 870 | 4,647 |
| Gain on debt extinguishment | 0 | 1,051 | 0 | 327 |
| Deferred tax provision (benefit) | -4,649 | 21,809 | 5,544 | -5,303 |
| Unrealized foreign currency transaction losses | -175 | -127 | -147 | 2,708 |
| Other, net | -88 | 686 | 2,396 | -33 |
| Accounts receivable | 15,135 | -5,986 | -1,551 | 2,949 |
| Prepaid expenses and other assets | -10,801 | -6,086 | -5,005 | -27,132 |
| Deferred costs | -809 | -735 | -816 | -3,068 |
| Accounts payable | 2,742 | 3,747 | -4,634 | 1,484 |
| Accrued expenses and other liabilities | 565 | -6,021 | -1,103 | -17,134 |
| Deferred revenue | 6,915 | 2,619 | 6,168 | 17,130 |
| Net cash provided by operating activities | 14,107 | 37,894 | 12,752 | 48,421 |
| Capital expenditures | 482 | 2,249 | 3,003 | 11,353 |
| Proceeds from revolving credit facility | - | - | 0 | - |
| Purchases of marketable securities | - | - | 0 | - |
| Payments of revolver credit facility | - | - | 0 | - |
| Sale and maturities of marketable securities | 2,539 | 886 | 2,019 | 3,493 |
| Proceeds from long-term debt, net of discount | - | - | 0 | - |
| Other investing activities | 390 | 426 | 565 | 1,145 |
| Payments for long-term debt issuance costs | - | - | 0 | 0 |
| Net cash used in investing activities | 1,667 | -1,789 | -1,549 | -9,005 |
| Principal payments of long-term debt | 0 | 27,600 | 0 | - |
| Principal payments of short-term debt | 0 | 0 | 0 | 87,089 |
| Common stock repurchases for tax withholdings for net settlement of equity awards | 13 | 7,541 | 180 | 2,200 |
| Principal payment of lease liabilities arising from a finance lease | 0 | 12 | 80 | 331 |
| Proceeds from the issuance of common stock | 562 | 7,499 | 675 | 2,204 |
| Net cash used in financing activities | 549 | -27,654 | 415 | -87,416 |
| Effects of exchange rate changes on cash and cash equivalents | -193 | -338 | -1,273 | 187 |
| Net change in cash and cash equivalents | 16,130 | 8,113 | 10,345 | -47,813 |
| Cash and cash equivalents at beginning of period | 92,130 | 84,017 | 121,485 | - |
| Cash and cash equivalents at end of period | 108,260 | 92,130 | 84,017 | - |
Cerence Inc. (CRNC)
Cerence Inc. (CRNC)